Lallemand F - Search Results

1

Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.

Mulder P, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemand F, Compagnon P, Macé B, Comoy E, Letac B, Thuillez C. Mulder P, et al. Among authors: lallemand f. Circulation. 1997 Sep 16;96(6):1976-82. doi: 10.1161/01.cir.96.6.1976. Circulation. 1997. PMID: 9323089

2

Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.

Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C. Mulder P, et al. Among authors: lallemand f. Circulation. 2004 Apr 6;109(13):1674-9. doi: 10.1161/01.CIR.0000118464.48959.1C. Epub 2004 Feb 23. Circulation. 2004. PMID: 14981003

3

Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure.

Banquet S, Gomez E, Nicol L, Edwards-Lévy F, Henry JP, Cao R, Schapman D, Dautreaux B, Lallemand F, Bauer F, Cao Y, Thuillez C, Mulder P, Richard V, Brakenhielm E. Banquet S, et al. Among authors: lallemand f. Circulation. 2011 Aug 30;124(9):1059-69. doi: 10.1161/CIRCULATIONAHA.110.010264. Epub 2011 Aug 8. Circulation. 2011. PMID: 21824923

4

Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure.

Mulder P, Richard V, Compagnon P, Henry JP, Lallemand F, Clozel JP, Koen R, Macé B, Thuillez C. Mulder P, et al. Among authors: lallemand f. J Am Coll Cardiol. 1997 Feb;29(2):416-21. doi: 10.1016/s0735-1097(96)00491-3. J Am Coll Cardiol. 1997. PMID: 9014998 Free article.

5

Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress.

Varin R, Mulder P, Richard V, Tamion F, Devaux C, Henry JP, Lallemand F, Lerebours G, Thuillez C. Varin R, et al. Among authors: lallemand f. Circulation. 1999 Jun 8;99(22):2951-7. doi: 10.1161/01.cir.99.22.2951. Circulation. 1999. PMID: 10359741

6

Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin.

Varin R, Mulder P, Tamion F, Richard V, Henry JP, Lallemand F, Lerebours G, Thuillez C. Varin R, et al. Among authors: lallemand f. Circulation. 2000 Jul 18;102(3):351-6. doi: 10.1161/01.cir.102.3.351. Circulation. 2000. PMID: 10899101

7

Prolonged cardiac dysfunction after withdrawal of chronic cocaine exposure in rats.

Moritz F, Monteil C, Mulder P, Derumeaux G, Bizet C, Renet S, Lallemand F, Richard V, Thuillez C. Moritz F, et al. Among authors: lallemand f. J Cardiovasc Pharmacol. 2003 Nov;42(5):642-7. doi: 10.1097/00005344-200311000-00010. J Cardiovasc Pharmacol. 2003. PMID: 14576513

8

Role of endogenous endothelin in endothelial dysfunction in murine model of systemic sclerosis: tight skin mice 1.

Richard V, Solans V, Favre J, Henry JP, Lallemand F, Thuillez C, Marie I. Richard V, et al. Among authors: lallemand f. Fundam Clin Pharmacol. 2008 Dec;22(6):649-55. doi: 10.1111/j.1472-8206.2008.00634.x. Fundam Clin Pharmacol. 2008. PMID: 19049669

9

Reduced cardiac remodelling and prevention of glutathione deficiency after omega-3 supplementation in chronic heart failure.

Fang Y, Favre J, Vercauteren M, Laillet B, Remy-Jouet I, Skiba M, Lallemand F, Dehaudt C, Monteil C, Thuillez C, Mulder P. Fang Y, et al. Among authors: lallemand f. Fundam Clin Pharmacol. 2011 Jun;25(3):323-32. doi: 10.1111/j.1472-8206.2010.00839.x. Fundam Clin Pharmacol. 2011. PMID: 20584202

10

Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.

Fang Y, Debunne M, Vercauteren M, Brakenhielm E, Richard V, Lallemand F, Henry JP, Mulder P, Thuillez C. Fang Y, et al. Among authors: lallemand f. J Cardiovasc Pharmacol. 2012 Mar;59(3):260-7. doi: 10.1097/FJC.0b013e31823e5e01. J Cardiovasc Pharmacol. 2012. PMID: 22075752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters